Implementation of MLC-based techniques for kidney protection as isolated organs during radiotherapy of abdominal malignancies
Introduction: Radiotherapy is one of the therapeutic options for malignancies associated with the abdominal cavity. However, the delivered dose must be limited to the kidneys' custom shielding blocks. This study aimed to propose a method in which kidney shielding blocks can be replaced with mu...
Saved in:
| Main Authors: | Warya Parvaii, Ghazal Mehri-Kakavand, Tahereh Hadisinia |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Ilam University of Medical Sciences
2025-05-01
|
| Series: | Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām |
| Subjects: | |
| Online Access: | http://sjimu.medilam.ac.ir/article-1-8569-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monte Carlo Simulation of the Gamma-Ray Transmissions for the newly Designed Shielding Blocks used in Radiotherapy
by: Nuray Yavuzkanat, et al.
Published: (2020-12-01) -
Dosimetric advantages of dual-layer MLC in hypofractionated stereotactic radiotherapy for multiple brain metastases: a comparative study with single-layer MLC
by: Changyou Zhong, et al.
Published: (2025-05-01) -
Nonylphenol exposure induces myocardial fibrosis via the RhoA/ROCK1/MLC-signaling pathway
by: Mucong Zheng, et al.
Published: (2025-07-01) -
Comparison of treatment planning for stereotactic radiosurgery and stereotactic body radiation therapy techniques with 2.5mm and 5mm multileaf collimator (MLC): A pilot study [version 2; peer review: 2 approved]
by: Senthil Manikandan, et al.
Published: (2025-03-01) -
The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild‐to‐moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double‐blind, placebo‐controlled trial
by: Christopher L.H. Chen, et al.
Published: (2019-01-01)